Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Despite No Surprises Is Annaly Capital Management, Inc. (NLY) Still a Buy?

Page 1 of 2

Annaly Capital (NLY)Annaly Capital Management, Inc. (NYSE:NLY) commenced operations in 1997 as a mortgage REIT with the objective of providing its shareholders elevated returns primarily through dividends. The company is self-managed and seeks to invest at least 75% of its total assets in high quality mortgage-backed securities and short term investments. The company’s charter allows the management to invest the remaining 25% of assets in unrated or less than high quality assets but that are at least investment grade. The company is currently invested in mortgage-backed securities backed by single-family residential mortgage loans as well as securities backed by loans on multi-family and commercial properties. At the end of the fourth quarter, around 93% of the securities that NLY held were fixed rate Agency MBS and debentures, while the remaining 7% was adjustable-rate Agency MBS and debentures. NLY entered in a contract to swap around 40% of the Agency MBS’s interest rates.

Earnings Review

Annaly Capital reported its performance for the fourth quarter of 2012 on Feb. 6, 2013. The reported bottom line of $700.5 million or $0.7 per common share for the quarter climbed 52% from a year ago, while it is over two-fold the bottom line of the linked quarter. Much of the sequential surge in the bottom line was a result of unrealized gains and losses on interest rate swaps Agency interest-only mortgage backed securities and net losses on extinguishment of Convertible Senior Notes.

Interest income has continued its downward journey since the second quarter of 2012. For the fourth quarter, interest income of $756.6 million fell 60 basis points over the linked quarter. Part of the reason for such a decline in interest income was the 4.3% decline in Agency mortgage-backed securities that NLY held. The weighted average yield on interest yielding assets declined 47 basis points over the same time period, causing the interest income to decline further.

Interest expense on the other hand surged. During the fourth quarter, NLY incurred $185.5 million in interest expense, compared to $181.9 million during the linked quarter. The rise in interest expense was a result of the higher cost of repurchase agreements, partially offset by a decline in the cost of Convertible Senior debt. The weighted average cost of funds during the fourth quarter dipped over the linked quarter from 1.6% to 1.55%.

As a result, net interest income of $571 million for the fourth quarter declined 1.4% over the linked quarter. Other income of $49.8 million declined 2% over the third quarter, largely due to lower net gains on disposal of investments, partially offset by higher net gains on trading assets. Unrealized gains on interest rate swaps produced $341.5 million against a loss of $104.2 million during the third quarter.

During the fourth quarter, NLY managed its general and administrative expenses well as they came down 36% sequentially to $40.1 million. Much of the improvement was a result of lower compensation expense, which still happens to be the largest contributor in expenses. The general and administrative expenses as a percentage of average assets declined to 0.12% from the linked quarter’s ratio of 0.19%.

Prepayment Speeds

Annaly reported 19% CPR for its MBS portfolio at the end of the fourth quarter. This is compared to 20% prepayment speed for its portfolio at the end of the third quarter. Lesser CPR means lower premium amortization cost. Therefore, net amortization of premiums and accretion of discounts for the fourth quarter were reported at $433.3 million, down 5% compared to the linked quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!